Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate QuidelOrtho Corporation before investing.

In this article, we go over a few key elements for understanding QuidelOrtho Corporation’s stock price such as:

• QuidelOrtho Corporation’s current stock price and volume
• Why QuidelOrtho Corporation’s stock price changed recently
• Upgrades and downgrades for QDEL from analysts
• QDEL’s stock price momentum as measured by its relative strength

About QuidelOrtho Corporation (QDEL)

Before we jump into QuidelOrtho Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

Want to learn more about QuidelOrtho Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about QuidelOrtho Corporation.

QuidelOrtho Corporation’s Stock Price as of Market Close

As of November 24, 2025, 11:18 AM, CST, QuidelOrtho Corporation’s stock price was $25.430.

QuidelOrtho Corporation is up 4.44% from its previous closing price of $24.350.

During the last market session, QuidelOrtho Corporation’s stock traded between $24.100 and $25.430. Currently, there are approximately 68.00 million shares outstanding for QuidelOrtho Corporation.

QuidelOrtho Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

QuidelOrtho Corporation Stock Price History

QuidelOrtho Corporation’s (QDEL) price is currently down 5.78% so far this month.

During the month of November, QuidelOrtho Corporation’s stock price has reached a high of $28.010 and a low of $19.500.

Over the last year, QuidelOrtho Corporation has hit prices as high as $49.450 and as low as $19.500. Year to date, QuidelOrtho Corporation’s stock is down 42.92%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused QuidelOrtho Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 21, 2025, there were 0 analysts who downgraded QuidelOrtho Corporation’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate QuidelOrtho Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on QuidelOrtho Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

QuidelOrtho Corporation’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about QuidelOrtho Corporation (QDEL) by visiting AAII Stock Evaluator.

Relative Price Strength of QuidelOrtho Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 21, 2025, QuidelOrtho Corporation has a weighted four-quarter relative price strength of -12.40%, which translates to a Momentum Score of 19 and is considered to be Very Weak.

Want to learn more about how QuidelOrtho Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

QuidelOrtho Corporation Stock Price: Bottom Line

As of November 24, 2025, QuidelOrtho Corporation’s stock price is $25.430, which is up 4.44% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like QuidelOrtho Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.